Treatment Protocol

Pre-treatment


Six-week intensive treatment phase


Post-treatment


neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.